Print Page  |  Report Abuse  |  Sign In  |  Register
Congressional Letter Resources

The following resources are in support of NAMSAP's letter to Congress issued April 2018 relative to the opioid epidmic and MSAs.

  1. What is Medicare Secondary Payer and What is a Medicare Set-Aside?
  2. CMS Reference Guide
  3. CMS Submission Quality Improvement Data Analytics
  4. CWCI Report: Opioids in Workers’ Compensation Medicare Set-Asides
  5. EBM Committee correspondence with CMS


NAMSAP Evidence-Based Medicine & Opioid/Narcotics in the MSA Initiative

2011 – NAMSAP creates EBM Committee.

2012 – NAMSAP features EBM experts at its conference.

2013 – NAMSAP initiates opioids in the MSA discussion.

2013 – CMS references EBM in its WCMSA Reference Guide.

2014 – NAMSAP plans for series on opioids.

2015 – NAMSAP begins to educate and recruit national leaders on the opioid epidemic in the MSA

2016 – NAMSAP initiates education series on Opioid In the MSA.  NAMSAP goes to Washington to meet with key officials on the Opioid in the MSA crisis.  NAMSAP through a national press release call for limits on opioids in the MSA.

2017 – NAMSAP works with members of Congress to address the opioid crisis in the MSA.  NAMSAP issues its second press release on establishing limits in the MSA. NAMSAP calls for CMS Administrator to address Opioids in the MSA.

2018 – NAMSAP continues to meet with policy makers to limit opioids in the MSA.


The National Alliance of Medicare Set Aside Professionals (NAMSAP) is the only non-profit association exclusively addressing the issues and challenges of Medicare Secondary Payer (MSP) compliance and its impact on workers’ compensation and liability settlements. Contact NAMSAP at 225.454.6164, or via

Community Search
Sign In

Latest News

NAMSAP Partners